therapeutic 2,187 words KG: ent-gene-79cf0358
section:therapeuticskind:therapeutictopic:parkinsons
Contents

Parkin Activators for Parkinson's Disease

🔬 Protein Info
Gene Symbolent-gene-79cf0358
ApproachOrganization
AAV-ParkinVarious academic groups
Small molecule activatorsAcademic/Industry
USP30 inhibitorsDenali Therapeutics
PINK1 activatorsMultiple
Gene editingResearch
USP30 inhibitorDenali Therapeutics
NAD+ boostersMultiple
Natural productsVarious
StrategyAdvantages
Parkin activatorsTarget mitochondrial quality control
LRRK2 inhibitorsAdvanced development
Alpha-synuclein targetingDisease-specific
Neurotrophic factorsNeuronal protection
CombinationRationale
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

Knowledge Graph

Related Hypotheses (7)

SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senesc
Score: 0.60
Epigenetic Memory Reprogramming via CRISPRa-Mediated Chromat
Score: 0.52
Conditional CRISPR Kill Switches for Aberrant Protein Cleara
Score: 0.45
Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Ci
Score: 0.45
Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.67

Related Analyses (19)

Do PINK1/PARKIN pathway enhancements rescue excitatory neuro
neurodegeneration · failed
Do PINK1/PARKIN pathway enhancements rescue excitatory neuro
neurodegeneration · failed
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Epigenetic reprogramming in aging neurons
neurodegeneration · archived
TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · failed

Related Experiments (30)

Cytochrome Therapeutics
clinical · proposed · Score: 0.46
AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera
validation · proposed · Score: 0.46
AAV-LRRK2 IND-Enabling Study Design
clinical · proposed · Score: 0.46
AAV Serotype Comparison for LRRK2 Knockdown in PD
validation · proposed · Score: 0.46
Alpha-Synuclein SAA Kinetics Study — Biological Staging Back
clinical · proposed · Score: 0.46